MYCN and alveolar rhabdomyosarcoma: Notably, MYCN's unique expression profile, predominantly absent in mature tissues but frequently dysregulated in a substantial portion of alveolar rhabdomyosarcoma cases, makes it an enticing target for immunotherapeutic interventions.